Benjamin Sydes
MRC Clinical Trials Unit at UCL · 8 works · 860 citations · h-index 3
Top works
- Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
- Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
- Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061).
- Can WBRT Be Omitted in NSCLC Patients with Inoperable Brain Metastases? Results from the UK MRC QUARTZ Randomised Clinical Trial
- How do the QUARTZ trial results inform future research for patients with brain metastases from non-small cell lung cancer?
- Can Whole Brain Radiotherapy be omitted from the treatment of Non-Small Cell Lung Cancer patients with brain metastases not amenable to stereotactic radiotherapy or surgery?: Results from the UK Medical Research Council QUARTZ randomised clinical trial
- 188: Quality of life after treatment for brain metastases: final demographic data from the QUARTZ trial